← Leaderboards
Robert Mark Vaughan
Van Andel Institute Graduate School
$463,628
Attributed
$463,628
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $110.4K · FY2019–24$200K$150K$100K$50K$0
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$463,628 · 2
By mechanism
K00$373,592 · 1
F99$90,036 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Dna Methylation”
- Sonia Minikel Vallabh · Broad Institute, Inc.$14,507,691
- Chongyuan Luo · University Of California Los Angeles$9,805,856
- Leonard Freedman · Leidos Biomedical Research, Inc.$9,392,562
- Michael-Christopher Keogh · Epicypher, Inc.$8,161,366
- Carl Rhodes · University Of Washington$8,047,567
- Himisha Beltran · Dana-Farber Cancer Inst$7,515,798
Research focus
Dna MethylationDna Modification MethylasesDna BiosynthesisDna BindingAcetylesteraseDna LigasesCell ProliferationChromatinComplementCrispr/Cas TechnologyBiochemicalBiochemistryBiologicalAreaBiophysicsBacterial ResistanceCellular BiologyCancer CellBasic ScienceColorectal CancerBindingCancer TypeCareerElements
Grant awards (6)
Characterizing genetic modifiers in tumor burden of Tuberous Sclerosis Complex$110,354
K00 · FY2024 · CA · contact PI
Characterizing genetic modifiers in tumor burden of Tuberous Sclerosis Complex$91,562
K00 · FY2023 · CA · contact PI
Characterizing genetic modifiers in tumor burden of Tuberous Sclerosis Complex$87,196
K00 · FY2022 · CA · contact PI
Characterizing genetic modifiers in tumor burden of Tuberous Sclerosis Complex$84,480
K00 · FY2021 · CA · contact PI
DNA methylation regulation through the UHRF1 oncoprotein$44,520
F99 · FY2020 · CA · contact PI
DNA methylation regulation through the UHRF1 oncoprotein$45,516
F99 · FY2019 · CA · contact PI